SpyGlass Pharma (SGP) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 20 163 sessions, February 6, 2026 to September 30, 2026
- Largest daily move
- +15% close of April 13, 2026
Company Description
SpyGlass Pharma (NASDAQ: SGP) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $883.2M.
SGP has declined 1.6% over the past month. The last closing price was $26.00.
For FY2025, SpyGlass Pharma reported net income of -$39.9M and diluted earnings per share of -$17.98.
This page collects what Stock Titan holds for SGP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SpyGlass Pharma (SGP) closed at $26.00 on September 30, 2026. Over the past month, the price has lost 1.6%.
SGP Metrics & Rankings
Price returns through September 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SpyGlass Pharma has 10 recent news articles, with the latest published today. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, conferences, earnings, clinical trial. View all SGP news →
SEC Filings
SpyGlass Pharma has filed 10 recent SEC filings, including 5 Form 8-K, 2 Form 10-Q, 1 Form 10-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on October 1, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SGP SEC filings →
Financial Highlights
operating income reached -$41.4M, and net income was -$39.9M. Diluted earnings per share stood at -$17.98. The company generated -$32.7M in operating cash flow. The current ratio was 12.67, measuring current assets divided by current liabilities.
Upcoming Events
Phase 3 enrollment completion
SpyGlass Pharma has 1 upcoming scheduled event. The next event, "Phase 3 enrollment completion", is scheduled for January 1, 2027 (in 91 days). Investors can track these dates to stay informed about potential catalysts that may affect the SGP stock price.
Short Interest History
Short interest in SpyGlass Pharma (SGP) currently stands at 1.2 million shares, up 12.1% from the previous reporting period, representing 3.8% of the float. Since February 2026, short interest has increased by 579.1%.
Days to Cover History
Days to cover for SpyGlass Pharma (SGP) currently stands at 11.6 days, down 26.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 967.9%. Across the settlements charted above, it has ranged from 1.1 to 19.4 days.
SGP Company Profile & Sector Positioning
SpyGlass Pharma (SGP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.